| NCT ID | NCT04407780 |
| Status | Recruiting |
| Phase | — |
| Sponsor | European Georges Pompidou Hospital |
| Condition | Cancer |
| Study Type | OBSERVATIONAL |
| Enrollment | 5,000 participants |
| Start Date | 2017-01-01 |
| Primary Completion | 2022-06-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 5,000 participants in total. It began in 2017-01-01 with a primary completion date of 2022-06-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Cardio-oncology is an emerging field. Most of the data available have been issued from either retrospective analysis, industry data or pharmacovigilance data. These data sources include a number of bias. CONFUCIUS is a single tertiary centre prospective registry including all patients who have been referred for cardio-oncology assessemnt. The objectives are to provide a comprehensive vue of cardoi-oncology, enable to detect early signals of cardiotoxicity and enhance ancillary projetcts aiming at specific populations (e.g., type of cancer) and/or drugs.
Eligibility Criteria
Inclusion Criteria: * referred to cardio-oncology Exclusion Criteria: * refusal to participate
Contact & Investigator
Frequently Asked Questions
Who can join the NCT04407780 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04407780 currently recruiting?
Yes, NCT04407780 is actively recruiting participants. Contact the research team at mariana.mirabel@aphp.fr for enrollment information.
Where is the NCT04407780 trial being conducted?
This trial is being conducted at Paris, France.
Who is sponsoring the NCT04407780 clinical trial?
NCT04407780 is sponsored by European Georges Pompidou Hospital. The trial plans to enroll 5,000 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.